Inhibikase Therapeutics, Inc. Common Stock (IKT) News

Latest headlines that mention IKT, newest first · each headline opens the original publisher

IKT quote

Last price: $1.52
Day change: -4.40%
Next earnings: 2026-11-13

Quote & chart Expected move Insider trading IV rank history

IKT headlines

latest coverage

Not much coverage yet. IKT has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Investing.com 2mo ago

H.C. Wainwright reiterates Inhibikase stock rating on FDA orphan drug status

General T3IKT

Seeking Alpha 3mo ago

Inhibikase sells $50M of common stock to RA Capital

General T2IKT

Investing.com 5mo ago

Form 13G Inhibikase Therapeutics For: 15 May

General T3IKT

Seeking Alpha 5mo ago

Inhibikase Therapeutics GAAP EPS of -$0.10 beats by $0.01

Earnings T2IKT

IKT news alerts

Get an alert by email or push when a new headline mentions IKT.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.